About the Authors
- Laura Kananen
-
Affiliations Research Program of Molecular Neurology, Faculty of Medicine, University of Helsinki, Helsinki, Finland, Department of Medical Genetics, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- Ida Surakka
-
Affiliations Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland, FIMM, Institute of Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
- Sami Pirkola
-
Affiliations Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland, Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland
- Jaana Suvisaari
-
Affiliation Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland
- Jouko Lönnqvist
-
Affiliations Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland, Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland
- Leena Peltonen
-
Affiliations Department of Medical Genetics, Faculty of Medicine, University of Helsinki, Helsinki, Finland, Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland, FIMM, Institute of Molecular Medicine Finland, University of Helsinki, Helsinki, Finland, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America, Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom
- Samuli Ripatti
-
Affiliations Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland, FIMM, Institute of Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
- Iiris Hovatta
-
* E-mail: iiris.hovatta@helsinki.fi
Affiliations Research Program of Molecular Neurology, Faculty of Medicine, University of Helsinki, Helsinki, Finland, Department of Medical Genetics, Faculty of Medicine, University of Helsinki, Helsinki, Finland, Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland
Competing Interests
Prof. Peltonen is a member of the board of Orion Pharma. The other authors report no competing interests.
Author Contributions
Conceived and designed the experiments: IH. Performed the experiments: LK IH. Analyzed the data: LK IS SP JS SR IH. Contributed reagents/materials/analysis tools: SP JS JL LP SR IH. Wrote the paper: LK SR IH.